table of content
1 Study Coverage
1.1 Celiac Drugs Product Introduction
1.2 Global Celiac Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Celiac Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Celiac Drugs Sales in Volume for the Year 2017-2028
1.3 United States Celiac Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Celiac Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Celiac Drugs Sales in Volume for the Year 2017-2028
1.4 Celiac Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Celiac Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Celiac Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Celiac Drugs Market Dynamics
1.5.1 Celiac Drugs Industry Trends
1.5.2 Celiac Drugs Market Drivers
1.5.3 Celiac Drugs Market Challenges
1.5.4 Celiac Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Celiac Drugs Market Segment by Type
2.1.1 First Line Of Treatment
2.1.2 Second Line Of Treatment
2.2 Global Celiac Drugs Market Size by Type
2.2.1 Global Celiac Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Celiac Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Celiac Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Celiac Drugs Market Size by Type
2.3.1 United States Celiac Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Celiac Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Celiac Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Celiac Drugs Market Segment by Application
3.1.1 Men
3.1.2 Women
3.1.3 Children
3.2 Global Celiac Drugs Market Size by Application
3.2.1 Global Celiac Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Celiac Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Celiac Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Celiac Drugs Market Size by Application
3.3.1 United States Celiac Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Celiac Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Celiac Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Celiac Drugs Competitor Landscape by Company
4.1 Global Celiac Drugs Market Size by Company
4.1.1 Top Global Celiac Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Celiac Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Celiac Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Celiac Drugs Price by Manufacturer (2017-2022)
4.2 Global Celiac Drugs Concentration Ratio (CR)
4.2.1 Celiac Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Celiac Drugs in 2021
4.2.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Celiac Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Celiac Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Celiac Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Celiac Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Celiac Drugs Market Size by Company
4.5.1 Top Celiac Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Celiac Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Celiac Drugs Sales by Players (2020, 2021 & 2022)
5 Global Celiac Drugs Market Size by Region
5.1 Global Celiac Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Celiac Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Celiac Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Celiac Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Celiac Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Celiac Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Celiac Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Celiac Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Celiac Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Celiac Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Celiac Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Celiac Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Celiac Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Celiac Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 ADMA Biologics
7.1.1 ADMA Biologics Corporation Information
7.1.2 ADMA Biologics Description and Business Overview
7.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 ADMA Biologics Celiac Drugs Products Offered
7.1.5 ADMA Biologics Recent Development
7.2 Amgen
7.2.1 Amgen Corporation Information
7.2.2 Amgen Description and Business Overview
7.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Amgen Celiac Drugs Products Offered
7.2.5 Amgen Recent Development
7.3 Anthera Pharmaceuticals
7.3.1 Anthera Pharmaceuticals Corporation Information
7.3.2 Anthera Pharmaceuticals Description and Business Overview
7.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered
7.3.5 Anthera Pharmaceuticals Recent Development
7.4 Bayer
7.4.1 Bayer Corporation Information
7.4.2 Bayer Description and Business Overview
7.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Bayer Celiac Drugs Products Offered
7.4.5 Bayer Recent Development
7.5 Biogen
7.5.1 Biogen Corporation Information
7.5.2 Biogen Description and Business Overview
7.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Biogen Celiac Drugs Products Offered
7.5.5 Biogen Recent Development
7.6 BioLineRx
7.6.1 BioLineRx Corporation Information
7.6.2 BioLineRx Description and Business Overview
7.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 BioLineRx Celiac Drugs Products Offered
7.6.5 BioLineRx Recent Development
7.7 Biotest
7.7.1 Biotest Corporation Information
7.7.2 Biotest Description and Business Overview
7.7.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Biotest Celiac Drugs Products Offered
7.7.5 Biotest Recent Development
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporation Information
7.8.2 Bristol-Myers Squibb Description and Business Overview
7.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered
7.8.5 Bristol-Myers Squibb Recent Development
7.9 Celgene
7.9.1 Celgene Corporation Information
7.9.2 Celgene Description and Business Overview
7.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Celgene Celiac Drugs Products Offered
7.9.5 Celgene Recent Development
7.10 Celimmune
7.10.1 Celimmune Corporation Information
7.10.2 Celimmune Description and Business Overview
7.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Celimmune Celiac Drugs Products Offered
7.10.5 Celimmune Recent Development
7.11 F Hoffmann-La Roche
7.11.1 F Hoffmann-La Roche Corporation Information
7.11.2 F Hoffmann-La Roche Description and Business Overview
7.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 F Hoffmann-La Roche Celiac Drugs Products Offered
7.11.5 F Hoffmann-La Roche Recent Development
7.12 ImmunogenX
7.12.1 ImmunogenX Corporation Information
7.12.2 ImmunogenX Description and Business Overview
7.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 ImmunogenX Products Offered
7.12.5 ImmunogenX Recent Development
7.13 Immunomedics
7.13.1 Immunomedics Corporation Information
7.13.2 Immunomedics Description and Business Overview
7.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Immunomedics Products Offered
7.13.5 Immunomedics Recent Development
7.14 ImmusanT
7.14.1 ImmusanT Corporation Information
7.14.2 ImmusanT Description and Business Overview
7.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 ImmusanT Products Offered
7.14.5 ImmusanT Recent Development
7.15 Innovate Biopharmaceuticals
7.15.1 Innovate Biopharmaceuticals Corporation Information
7.15.2 Innovate Biopharmaceuticals Description and Business Overview
7.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Innovate Biopharmaceuticals Products Offered
7.15.5 Innovate Biopharmaceuticals Recent Development
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporation Information
7.16.2 Johnson & Johnson Description and Business Overview
7.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Johnson & Johnson Products Offered
7.16.5 Johnson & Johnson Recent Development
7.17 Kedrion Biopharma
7.17.1 Kedrion Biopharma Corporation Information
7.17.2 Kedrion Biopharma Description and Business Overview
7.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Kedrion Biopharma Products Offered
7.17.5 Kedrion Biopharma Recent Development
7.18 LFB Group
7.18.1 LFB Group Corporation Information
7.18.2 LFB Group Description and Business Overview
7.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.18.4 LFB Group Products Offered
7.18.5 LFB Group Recent Development
7.19 Merck
7.19.1 Merck Corporation Information
7.19.2 Merck Description and Business Overview
7.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.19.4 Merck Products Offered
7.19.5 Merck Recent Development
7.20 Novartis
7.20.1 Novartis Corporation Information
7.20.2 Novartis Description and Business Overview
7.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2017-2022)
7.20.4 Novartis Products Offered
7.20.5 Novartis Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Celiac Drugs Industry Chain Analysis
8.2 Celiac Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Celiac Drugs Distributors
8.3 Celiac Drugs Production Mode & Process
8.4 Celiac Drugs Sales and Marketing
8.4.1 Celiac Drugs Sales Channels
8.4.2 Celiac Drugs Distributors
8.5 Celiac Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
